All News

Kale is incredibly popular. It's everywhere.

JCAR017 had promising complete response and objective response rates in treating patients with diffuse large B-cell lymphoma (DLBCL) in a recently presented study.

Reforms are needed high up within the drug distribution chain, concluded a panel of pharmaceutical professionals at the Oncology Market Access & Pricing conference held in Philadelphia this week by eyeforpharma.

There is hot debate over whether full-body skin exams should be done each year to help in early detection of both non-melanoma and melanoma skin cancers.

How decreasing my pace has made me acutely aware of the outside noise that distracts us from the life’s most important things, which aren’t things at all.

Green can be a beautiful color full of life, but it can also be the color of chemotherapy.

Apreciating all the positives amongst the disease of cancer

Three times comments about my cancer made me say, "Huh?"

The Food and Drug Administration (FDA) granted an approval to Darzalex (daratumumab) for use in combination with Pomalyst (pomalidomide) and dexamethasone for patients who have multiple myeloma who have two or more prior therapies, including a proteasome inhibitor and Revlimid (lenalidomide).

Taking the good with the bad and living life despite cancer

Taking back control of your life with small wins.

The term "palliative care" used to mean keeping a patient comfortable until he or she died. Today it has evolved into a discipline to help patients live longer and better.

When used as a neoadjuvant therapy for patients with muscle-invasive bladder cancer (MIBC), split-dose of gemcitabine and cisplatin has a beneficial response and a high safety profile, according to a study presented at the 2017 American Urological Association Annual Meeting.

Pairing two drugs that have shown to be effective in treating lymphoma might be the next step for mantle cell lymphoma treatment.

The possibility of carrying the BRCA gene mutation can be concerning to women who've been diagnosed with cancer especially when their children may eventually be affected.

Eating well is hard. Diet is personal.

We must remember what happened but also move forward.

Superior progression-free survival (PFS) was seen in patients with ovarian cancer who previously had a partial response (PR) to platinum-based therapy when they took Zejula (niraparib). This response was seen in patients with or without germline BRCA mutations, according to data from the ENGOT-OV16/NOVA trial presented at the 2017 ASCO Annual Meeting.

Progression-free survival (PFS) was not significantly improved with the combination of dalantercept plus Inlyta (axitinib) in patients with advanced renal cell carcinoma (RCC) compared with placebo, according to the results from the phase 2 DART trial.

A cancer survivor examines the link between health and humor.

The star heads into the world of ongoing breast cancer treatment just as a major new study of metastatic breast cancer in the United States gives a little more hope to those with the disease

After my cancer diagnosis, I realized that the only person to speak up for me was me. This is how I learned to speak up for myself and talk to those who represent me in Congress.

Merck will be pausing two trials testing Keytruda in patients with multiple myeloma.

Imbruvica (ibrutinib) continues to demonstrate benefit in patients with chronic lymphocytic leukemia (CLL) who had at least one prior therapy, according to a four-year follow-up of the RESONATE study, which compared the BTK inhibitor to Arzerra (ofatumumab).

Changing the perception of what it means to be a survivor

When we are surviving cancer, when we want to see everybody else survive it too, another death is hard to take. When somebody passes, we are reminded of our own mortality—and distant losses—even as we mourn. Poetry helps.

How do we define how we feel and answer the question, "How do you feel?"

Tagrisso (osimertinib) had positive outcomes for patients with T790M-positive non–small cell lung cancer (NSCLC) for central nervous system (CNS) metastases.